Pieris Pharmaceuticals
PIRS
#9612
Rank
โ‚ฌ20.05 M
Marketcap
15,14ย โ‚ฌ
Share price
-1.05%
Change (1 day)
-17.63%
Change (1 year)

Revenue for Pieris Pharmaceuticals (PIRS)

Revenue in 2024 (TTM): โ‚ฌ36.94 Million

According to Pieris Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ37.62 Million. In 2022 the company made a revenue of โ‚ฌ24.14 Million a decrease over the revenue in the year 2021 that were of โ‚ฌ27.74 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pieris Pharmaceuticals from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ36.94 M
2022 โ‚ฌ24.14 M-12.96%
2021 โ‚ฌ27.74 M16.37%
2020 โ‚ฌ23.84 M-42.29%
2019 โ‚ฌ41.31 M62.4%
2018 โ‚ฌ25.43 M20.77%
2017 โ‚ฌ21.06 M280.04%
2016 โ‚ฌ5.54 M137.32%
2015 โ‚ฌ2.33 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ95.31 M 153.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ5.99 M-84.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ26.39 B 70,059.99%๐Ÿ‡บ๐Ÿ‡ธ USA